Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger order growth.